Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Oxaliplatin in Second-line Non-adenocarcinoma NSCLC
NCT01497041Phase 2Unknown
- Sponsor
- Korean South West Oncology Group
- Start
- Feb 2011
- Primary completion
- Dec 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, oxaliplatin in non-small cell lung cancer (NSCLC), sponsored by Korean South West Oncology Group. Status: unknown.
02
Drugs
docetaxeloxaliplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01497041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497041.